Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Arcutis Biotherapeutics, Inc. (ARQT)  
$8.10 0.32 (4.11%) as of 4:30 Wed 6/12


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 106,469,000
Market Cap: 862.40(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.84 - $12.53
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 8
Insider 3/6 Months : 8.6
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Arcutis Biotherapeutics is a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with unmet medical needs. Co.'s product candidate, topical roflumilast cream, is used for plaque psoriasis, including intertriginous psoriasis, as well as atopic dermatitis. Co. is developing a topical foam formulation of roflumilast for the treatment of scalp psoriasis and seborrheic dermatitis; ARQ-252, a topical cream formulation of a small molecule inhibitor of Janus kinase type 1 for chronic hand eczema and vitiligo; and ARQ-255, an alternative topical formulation of ARQ-252 designed to reach into the skin in order to treat alopecia areata.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 21,052 101,052 352,515
Total Buy Value $0 $199,994 $399,994 $5,409,328
Total People Bought 0 1 1 2
Total Buy Transactions 0 1 2 4
Total Shares Sold 125,402 156,105 159,560 614,286
Total Sell Value $1,090,022 $1,420,148 $1,435,111 $10,777,289
Total People Sold 6 6 6 11
Total Sell Transactions 9 15 17 59
End Date 2024-03-14 2023-12-12 2023-06-13 2022-06-13

   
Records found: 335
  Page 4 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Turney Patricia A. SVP, Operations   •       –      –    2023-03-02 4 AS $15.82 $22,664 D/D (1,432) 45,693 -39%     
   Burrows Scott L Chief Financial Officer   •       –      –    2023-03-02 4 AS $15.82 $22,696 D/D (1,434) 38,406 -39%     
   Lock Kenneth A. Chief Commercial Officer   •       –      –    2023-03-02 4 AS $15.82 $22,664 D/D (1,432) 43,260 -39%     
   Watanabe Todd Franklin See Remarks   •       •      –    2023-02-28 4 AS $16.17 $37,878 D/D (2,343) 374,564 -40%     
   Osborne David W Chief Technical Officer   •       –      –    2023-02-28 4 AS $16.17 $12,804 D/D (792) 255,857 -40%     
   Turney Patricia A. SVP, Operations   •       –      –    2023-02-28 4 AS $16.17 $15,132 D/D (936) 47,125 -40%     
   Burrows Scott L Chief Financial Officer   •       –      –    2023-02-28 4 AS $16.17 $6,725 D/D (416) 39,840 -40%     
   Lock Kenneth A. Chief Commercial Officer   •       –      –    2023-02-28 4 AS $16.17 $15,132 D/D (936) 44,692 -40%     
   Welgus Howard G. Director   –       •      –    2023-02-15 4 AS $16.98 $144,352 D/D (8,500) 165,825 -51%     
   Welgus Howard G. Director   –       •      –    2023-02-15 4 OE $1.68 $14,285 D/D 8,500 174,325     -
   Watanabe Todd Franklin See Remarks   •       •      –    2023-02-14 4 AS $17.02 $8,800 D/D (517) 376,907 -50%     
   Watanabe Todd Franklin See Remarks   •       •      –    2023-02-13 4 AS $17.00 $8,211 D/D (483) 377,424 -48%     
   Watanabe Todd Franklin See Remarks   •       •      –    2023-02-01 4 AS $17.00 $17,003 D/D (1,000) 377,907 -39%     
   Welgus Howard G. Director   –       •      –    2023-01-17 4 AS $13.72 $116,655 D/D (8,500) 165,825 -43%     
   Welgus Howard G. Director   –       •      –    2023-01-17 4 OE $1.68 $14,280 D/D 8,500 174,325     -
   Burnett Patrick See Remarks   •       –      –    2023-01-03 4 S $15.01 $22,136 D/D (1,475) 41,564 32%     
   Watanabe Todd Franklin See Remarks   •       •      –    2022-12-07 4 AS $17.06 $17,060 D/D (1,000) 378,907 -20%     
   Matsuda Masaru See Remark   •       –      –    2022-11-21 4 S $18.19 $31,289 D/D (1,720) 19,535 41%     
   Matsuda Masaru See Remark   •       –      –    2022-11-18 4 A $0.00 $0 D/D 4,875 21,255     -
   Welgus Howard G. Director   –       •      –    2022-11-15 4 AS $20.01 $68,103 D/D (3,403) 165,825 -45%     
   Welgus Howard G. Director   –       •      –    2022-11-15 4 OE $1.68 $1,714 D/D 1,020 169,228     -
   Watanabe Todd Franklin See Remarks   •       •      –    2022-11-07 4 AS $18.00 $18,004 D/D (1,000) 379,907 -38%     
   Watanabe Todd Franklin President and CEO   •       •      –    2022-10-07 4 AS $19.51 $19,510 D/D (1,000) 380,907 -15%     
   Welgus Howard G. Director   –       •      –    2022-10-04 4 AS $20.29 $121,766 D/D (6,000) 168,208 -16%     
   Burrows Scott L Chief Financial Officer   •       –      –    2022-09-16 4 OE $1.68 $8,403 D/D 5,000 40,256     -
  335 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us